In detox, moderate doses (e.g., 2,50010,000 IU per day, depending on baseline deficiency) may be used under medical supervision, especially in individuals with documented deficiency
After the Icelandic Medicines Agency published initial safety concerns in July 2023, regulatory bodies worldwide have launched investigations to assess the potential risk of suicidality among GLP-1 receptor agonist users
GLP-1 drugs were originally developed to treat type 2 diabetes, but many people now use them as a medicine for weight loss
Indeed, a 2022 study found that after stopping a regimen of Semaglutide, the active ingredient in Ozempic, patients regained 2/3rds of the weight loss within one year
While this does not directly involve hydroxyzine, you must ensure your provider has a full picture of your family medical history before starting any GLP-1 program
The solution might look perfectly clear and normal while containing significantly less active semaglutide